Keishi Sugimachi
Overview
Explore the profile of Keishi Sugimachi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
201
Citations
2860
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sugimachi K, Tomino T, Shimagaki T, Onishi E, Koga Y, Taguchi K, et al.
Clin J Gastroenterol
. 2025 Mar;
PMID: 40053258
Patients with pancreaticobiliary maljunction (PBM) have a high risk of biliary tract cancer (BTC). The risk of pancreatic cancer is also reported to be higher in patients with PBM compared...
2.
Sugiyama M, Kasagi Y, Yokomizo R, Terashi M, Oonishi E, Nagai T, et al.
Anticancer Res
. 2025 Mar;
45(3):1233-1239.
PMID: 40037848
Background/aim: Locally advanced rectal cancer (LARC) with adjacent organ invasion presents significant surgical challenges, particularly in achieving negative circumferential resection margins (CRM). Transanal total mesorectal excision (TaTME) offers improved visualization...
3.
Prognostic impact of osteosarcopenia on postoperative outcomes in patients with biliary tract cancer
Shimagaki T, Sugimachi K, Tomino T, Onishi E, Koga N, Kasagi Y, et al.
Surg Today
. 2024 Dec;
PMID: 39625483
Purpose: Frailty, characterized by sarcopenia and osteopenia, is associated with poor survival after the resection of biliary tract cancer (BTC). Osteosarcopenia, the coexistence of sarcopenia and osteopenia, has recently been...
4.
Sugimachi K, Shimagaki T, Tomino T, Onishi E, Mano Y, Iguchi T, et al.
Ann Gastroenterol Surg
. 2024 Nov;
8(6):1118-1125.
PMID: 39502730
Aims: Splenic vein occlusion (SpVO) due to a pancreatic tumor may result in the development of collateral circulation and left-sided portal hypertension. This study aimed to investigate the impact of...
5.
Iseda N, Itoh S, Toshima T, Yoshiya S, Bekki Y, Tsutsui Y, et al.
Surg Today
. 2024 Aug;
PMID: 39192138
Background And Purpose: In recent years, new systemic therapies have been developed for hepatocellular carcinoma (HCC). The aim of this study was to evaluate the prognosis of patients with unresectable...
6.
Tomino T, Sugimachi K, Shimagaki T, Onishi E, Harimoto N, Sugiyama M, et al.
Asian J Endosc Surg
. 2024 Aug;
17(4):e13377.
PMID: 39187916
Introduction: Achieving an adequate surgical plane through optimal traction is crucial for liver parenchymal transection in minimally invasive liver surgery (MILS). MILS is more technically demanding than open liver surgery...
7.
Iguchi T, Mita J, Iseda N, Sasaki S, Harada N, Ninomiya M, et al.
Ann Gastroenterol Surg
. 2024 Jan;
8(1):172-181.
PMID: 38250679
Aim: Postoperative dysphagia after emergency abdominal surgery (EAS) in patients of advanced age has become problematic, and appropriate dysphagia management is needed. This study was performed to identify predictive factors...
8.
Shimagaki T, Sugimachi K, Mano Y, Onishi E, Iguchi T, Nakashima Y, et al.
Ann Gastroenterol Surg
. 2023 Nov;
7(6):977-986.
PMID: 37927935
Aim: This study was performed to investigate the relationship between the preoperative cachexia index (CXI) and long-term outcomes in patients who have undergone radical resection of pancreatic ductal adenocarcinoma (PDAC)....
9.
Mano Y, Sugimachi K, Shimagaki T, Tomino T, Onishi E, Lee L, et al.
Surg Case Rep
. 2023 Sep;
9(1):173.
PMID: 37773552
Background: Liver metastasis of pure squamous cell carcinoma (SCC) from pancreatic ductal adenocarcinoma has not been previously reported. Case Presentation: A 66-year-old man underwent a computed tomography scan 3 years...
10.
Shimagaki T, Sugimachi K, Mano Y, Tomino T, Onishi E, Taguchi K, et al.
Clin J Gastroenterol
. 2023 Sep;
17(1):93-99.
PMID: 37751079
Chronic expanding hematoma (CEH) is defined as a hematoma that grows slowly over a month or longer. CEH with a primary hepatic origin is extremely rare. An 85-year-old man presented...